A detailed history of Cypress Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cypress Asset Management Inc holds 40,966 shares of MRK stock, worth $5.07 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
40,966
Previous 41,286 0.78%
Holding current value
$5.07 Million
Previous $4.5 Million 20.11%
% of portfolio
1.51%
Previous 1.37%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 11, 2024

SELL
$113.24 - $131.95 $36,236 - $42,224
-320 Reduced 0.78%
40,966 $5.41 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $24,243 - $26,382
242 Added 0.59%
41,286 $4.5 Million
Q3 2023

Feb 09, 2024

BUY
$102.95 - $114.33 $30,679 - $34,070
298 Added 0.72%
41,584 $4.28 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $15,531 - $16,928
143 Added 0.35%
41,044 $4.74 Million
Q1 2023

May 25, 2023

SELL
$102.94 - $114.86 $83,381 - $93,036
-810 Reduced 1.94%
40,901 $4.35 Million
Q4 2022

Feb 28, 2023

SELL
$87.44 - $112.11 $173,568 - $222,538
-1,985 Reduced 4.54%
41,711 $4.63 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $28,740 - $32,286
-340 Reduced 0.77%
43,696 $3.76 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $94,343 - $106,943
-1,130 Reduced 2.5%
44,036 $4.02 Million
Q1 2022

Jun 06, 2022

SELL
$73.51 - $82.4 $569,776 - $638,682
-7,751 Reduced 14.65%
45,166 $3.71 Million
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $124,032 - $155,366
-1,716 Reduced 3.14%
52,917 $4.06 Million
Q3 2021

Oct 18, 2021

SELL
$71.68 - $78.83 $63,006 - $69,291
-879 Reduced 1.58%
54,633 $4.1 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $197,360 - $218,300
-2,807 Reduced 4.81%
55,512 $4.32 Million
Q1 2021

Apr 22, 2021

SELL
$68.86 - $81.11 $70,925 - $83,543
-1,030 Reduced 1.74%
58,319 $4.5 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $5,382 - $5,973
75 Added 0.13%
59,349 $4.86 Million
Q3 2020

Oct 26, 2020

BUY
$73.18 - $82.95 $27,588 - $31,272
377 Added 0.64%
59,274 $4.92 Million
Q2 2020

Jul 28, 2020

SELL
$70.42 - $80.13 $3.59 Million - $4.08 Million
-50,915 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $33,073 - $45,842
522 Added 1.04%
50,915 $3.92 Million
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $99,224 - $111,963
1,279 Added 2.6%
50,393 $4.58 Million
Q3 2019

Oct 21, 2019

SELL
$76.08 - $82.93 $54,777 - $59,709
-720 Reduced 1.44%
49,114 $4.13 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $48,608 - $56,786
696 Added 1.42%
49,834 $4.18 Million
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $179,516 - $204,748
-2,580 Reduced 4.99%
49,138 $4.09 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $323,916 - $375,900
-4,965 Reduced 8.76%
51,718 $3.95 Million
Q3 2018

Oct 19, 2018

SELL
$57.69 - $67.84 $223,260 - $262,540
-3,870 Reduced 6.39%
56,683 $4.02 Million
Q2 2018

Jul 27, 2018

SELL
$50.83 - $59.72 $290,493 - $341,299
-5,715 Reduced 8.62%
60,553 $3.68 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $1.76 Million - $2.04 Million
-34,449 Reduced 34.2%
66,268 $3.61 Million
Q4 2017

Jan 31, 2018

SELL
$51.62 - $61.64 $204,931 - $244,710
-3,970 Reduced 3.79%
100,717 $5.67 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $6.14 Million - $6.61 Million
104,687
104,687 $6.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cypress Asset Management Inc Portfolio

Follow Cypress Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.